Comprehensive Management of Diabetic Ketoacidosis (DKA) in Adults
The management of DKA in adults requires immediate fluid resuscitation with isotonic saline (0.9% NaCl) at 15-20 ml/kg/hour for the first hour, followed by insulin therapy, electrolyte replacement, and identification of precipitating factors to reduce mortality. 1
Diagnosis and Initial Assessment
- DKA diagnostic criteria: blood glucose >250 mg/dl, arterial pH <7.3, bicarbonate <15 mEq/l, and moderate ketonuria or ketonemia 1
- Obtain arterial blood gases, complete blood count with differential, urinalysis, blood glucose, blood urea nitrogen, electrolytes with calculated anion gap, serum ketones, osmolality, chemistry profile, creatinine levels, and electrocardiogram 1
- Obtain chest X-ray and bacterial cultures (urine, blood, throat) if infection is suspected 1
- Differentiate from other causes of high anion gap metabolic acidosis including alcoholic ketoacidosis, lactic acidosis, salicylate ingestion, methanol, ethylene glycol, paraldehyde ingestion, and chronic renal failure 1
Fluid Therapy
- Begin with isotonic saline (0.9% NaCl) at 15-20 ml/kg/h during the first hour (approximately 1-1.5 liters in average adult) to restore intravascular volume and renal perfusion 1
- After initial resuscitation:
- Correct serum sodium for hyperglycemia (add 1.6 mEq to sodium value for each 100 mg/dl glucose >100 mg/dl) 1
- Target fluid replacement to correct estimated deficits within 24 hours 1
- Monitor fluid input/output, blood pressure, and clinical examination to assess progress 1
Insulin Therapy
- Start continuous intravenous regular insulin without an initial bolus at 0.1 units/kg/hour 2
- Continue insulin therapy until resolution of ketoacidosis, regardless of glucose levels 2
- Add dextrose 5% to intravenous fluids when serum glucose reaches 250 mg/dL while continuing insulin infusion 2
- Target glucose between 150-200 mg/dL until DKA resolution parameters are met 2
- Transition to subcutaneous insulin when DKA resolves and patient can eat 2
- Administer basal insulin 2-4 hours before stopping IV insulin to prevent recurrence of ketoacidosis 2
Electrolyte Management
- Monitor potassium closely as total body potassium is depleted despite potentially normal or elevated initial serum levels due to acidosis 1
- Once renal function is assured and serum potassium is known, add 20-30 mEq/L potassium (2/3 KCl and 1/3 KPO₄) to IV fluids when serum levels fall below 5.5 mEq/L 1
- Typical electrolyte deficits in DKA include: potassium (3-5 mEq/kg), phosphate (5-7 mEq/kg), magnesium (1-2 mEq/kg), and calcium (1-2 mEq/kg) 1
- Bicarbonate administration is generally not recommended as it does not improve outcomes 3
Monitoring During Treatment
- Check blood glucose hourly 2
- Check electrolytes, blood urea nitrogen, creatinine, and osmolality every 2-4 hours until stable 1, 2
- Monitor venous pH and anion gap to assess resolution of acidosis 2
- Assess for signs of volume overload, particularly in patients with renal or cardiac compromise 1, 2
- Ensure the induced change in serum osmolality does not exceed 3 mOsm/kg/h to prevent cerebral edema 1
- Continue monitoring for at least 24 hours after resolution of DKA 2
Resolution Criteria
Special Considerations
- In hemodialysis patients, monitor cardiac and respiratory status closely during fluid administration 2
- Recent evidence suggests balanced crystalloids (Ringer's lactate or Plasma-Lyte) may lead to faster DKA resolution than saline (median 13.0 vs 16.9 hours) 4
- Cerebral edema is a rare but serious complication, more common in pediatric patients than adults 5
Prevention Strategies
- Develop a structured discharge plan tailored to the individual patient 2
- Schedule follow-up appointments prior to discharge 2
- Provide patient education on:
Common Pitfalls to Avoid
- Failing to identify and treat the precipitating cause (infection is most common at 30-50%) 7
- Discontinuing insulin too early before ketosis resolves 2
- Inadequate potassium replacement leading to arrhythmias 1
- Overly rapid correction of hyperglycemia and hyperosmolality 1
- Insufficient monitoring of electrolytes and acid-base status 2
- Not overlapping IV insulin with subcutaneous insulin during transition 2